ArticleJournal of clinical medicine2023

Efficacy, Safety, and Subject Satisfaction of PrabotulinumtoxinA for Moderate-to-Severe Crow's Feet: A Phase IV, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial.

Soo-Kyung Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.